World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
33580
World Ranking
10463
National Ranking
329

Overview

Marc Sanson is affiliated with Sorbonne University in France. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, they have contributed extensively to Genetics, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, and Radiology, Nuclear Medicine and Imaging.

The scientist's work covers a range of topics related to neurological and oncological conditions, with a significant emphasis on glioma diagnosis and treatment. Other main topics include radiomics and machine learning in medical imaging, cancer genomics and diagnostics, management of meningioma and schwannoma, cancer, hypoxia, and metabolism, brain metastases and treatment, and ferroptosis and cancer prognosis.

Marc Sanson has been published frequently in various scientific journals. The venues where they have the most publications include:

  • Neuro-Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Journal of Clinical Oncology
  • Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition

They have collaborated repeatedly with a number of coauthors:

  • Franck Bielle
  • Ahmed Idbaïh
  • Alberto Pïcca
  • Anna Luisa Di Stefano
  • Mehdi Touat

Notable recent papers include:

  • "Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions," 2020, Neuro-Oncology
  • "Mechanisms and therapeutic implications of hypermutation in gliomas," 2020, Nature
  • "Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities," 2021, Nature Cancer
  • "Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study," 2021, The Lancet Oncology
  • "Challenges in glioblastoma research: focus on the tumor microenvironment," 2022, Trends in cancer

Best Publications

  • Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

    Guy A. Rouleau;Philippe Merel;Mohini Lutchman;Marc Sanson;Marc Sanson

  • Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas

    Marc Sanson;Yannick Marie;Sophie Paris;Ahmed Idbaih

  • Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

    Martin J. van den Bent;Antoine F. Carpentier;Alba A. Brandes;Marc Sanson

  • Genome-wide association study identifies five susceptibility loci for glioma

    Sanjay Shete;Fay J. Hosking;Lindsay B. Robertson;Sara E. Dobbins

  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    Patrick Y. Wen;Michael Weller;Eudocia Quant Lee;Brian M. Alexander

  • Clinical trial of blood-brain barrier disruption by pulsed ultrasound

    Alexandre Carpentier;Michael Canney;Alexandre Vignot;Vincent Reina

  • Mechanisms and therapeutic implications of hypermutation in gliomas.

    Mehdi Touat;Mehdi Touat;Mehdi Touat;Yvonne Y. Li;Yvonne Y. Li;Adam N. Boynton;Adam N. Boynton;Liam F. Spurr;Liam F. Spurr

  • IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

    C. Houillier;X. Wang;G. Kaloshi;K. Mokhtari

  • MGMT testing—the challenges for biomarker-based glioma treatment

    Wolfgang Wick;Michael Weller;Martin van den Bent;Marc Sanson

  • A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry.

    Soufiane El Hallani;Blandine Boisselier;Florent Peglion;Audrey Rousseau

  • Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

    Martin J van den Bent;Brigitta Baumert;Sara C Erridge;Michael A Vogelbaum;Michael A Vogelbaum

  • Glioblastoma targeted therapy: updated approaches from recent biological insights

    M. Touat;M. Touat;A. Idbaih;M. Sanson;K.L. Ligon

  • Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions

    K. Hoang-Xuan;L. Capelle;M. Kujas;S. Taillibert

  • Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire

    Carole Soussain;Khê Hoang-Xuan;Luc Taillandier;Emmanuelle Fourme

  • IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

    Martin J. van den Bent;Hendrikus J. Dubbink;Yannick Marie;Alba A. Brandes

  • MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

    Martin J. van den Bent;Hendrikus J. Dubbink;Marc Sanson;Cathleen R. van der Lee-Haarloo

  • Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.

    Jean-Sébastien Guillamo;Alain Créange;Chantal Kalifa;Jacques Grill

  • Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors

    Beatrice S Melin;Jill S Barnholtz-Sloan;Margaret R Wrensch;Christoffer Johansen

  • Temozolomide for low-grade gliomas: Predictive impact of 1p/19q loss on response and outcome

    G. Kaloshi;A. Benouaich-Amiel;F. Diakite;S. Taillibert

  • All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2

    M. Labussière;A. Idbaih;X.-W. Wang;Y. Marie

Frequent Co-Authors

Khê Hoang-Xuan
Khê Hoang-Xuan Université Paris Cité
Ahmed Idbaih
Ahmed Idbaih Sorbonne University
Jean-Yves Delattre
Jean-Yves Delattre Université Paris Cité
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam
Olivier Delattre
Olivier Delattre PSL University
Dominique Figarella-Branger
Dominique Figarella-Branger Aix-Marseille University
Johan M. Kros
Johan M. Kros Erasmus University Rotterdam
Pieter Wesseling
Pieter Wesseling University of Amsterdam
Gilles Thomas
Gilles Thomas Grenoble Alpes University
Richard S. Houlston
Richard S. Houlston Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always mean taking the traditional route to an MD. There are a variety of online degree programs and career pathways for those interested in healthcare, offering both flexibility and speed. For nursing professionals seeking career advancement, the easiest online dnp programs can help practicing nurses gain leadership positions while managing work and life responsibilities.

If you’re considering starting your healthcare career quickly, lpn online programs let you become a Licensed Practical Nurse in less time, providing essential skills for working directly with patients. For those interested in mental health, specialized online programs like the psych np programs prepare nurses for psychiatric and mental health nurse practitioner roles, an area in high demand.

Alternatively, for a leadership role outside of direct patient care, an online health management degree opens doors to administrative and executive opportunities within healthcare organizations. These options allow students to tailor their educational journeys to align with their career goals and personal circumstances.

Best Scientists Citing Marc Sanson

Trending Scientists

Recently Published Articles